Le to be promoted to Associate Professor
We are pleased to announce that the Promotions and Tenure Committee at UT Southwestern has recommended that Lu Le, M.D., be promoted from Assistant Professor to the academic rank of Associate Professor with Tenure, effective September 1, 2015. Congratulations, Lu!!
Turrentine wins Award of Distinction
Congratulations to Jake Turrentine, M.D., chief resident in the Dermatology Department, who won the 2015 Winter Clinical Derm Hawaii Residents of Distinction Award, and was able to attend the Hawaii Winter Clinical Dermatology Conference in Maui in January 2015. While at the conference, he won second place in the Residents of Distinction Competition with his presentation on "DC-HIL is a blood marker and potential treatment target for melanoma.
Gill wins UT Southwestern PSTP Award
Jennifer Gill, M.D., Ph.D., a second year resident in the department, is a recipient of the UT Southwestern Physician Scientist Training Program (PSTP), an institutional program which provides individuals who desire research training and have a commitment to an academic career up to three years of salary support during the years of their research training. Dr. Gill will be doing her research training in the laboratory of Sean Morrison, Ph.D., Director of the Children's Medical Center Research Institute at UT Southwestern and a Howard Hughes investigator. Dr. Morrison’s lab studies the mechanisms that regulate stem cell self-renewal and stem cell aging, and the role these mechanisms play in cancer.
Pandya Spearheads New Atlas of Skin of Color
Congratulations to Amit Pandya, M.D., for his recently published Atlas of Skin of Color. He is co-editor of this publication, along with Dr. Diane Jackson-Richards, M.D. from Henry Ford Hospital. The Atlas of Skin of Color includes 50 chapters, more than 400 images, and concise discussions to address the presentation of common skin disorders in pigmented patients.
Le Lab Identifies Cell of Origin for Plexiform Neurofibromas
Lu Le, M.D., Ph.D., and postdoctoral researcher Zhiguo Chen have determined the cell of origin for plexiform neurofibromas, large disfiguring tumors found in the genetic condition Neurofibromatosis type 1. Ten percent of these tumors become malignant – the identification of the cell of origin for plexiform neurofibromas is an important step towards drug discoveries that can stop cancer development.
Ariizumi/Cruz Lab Receive CPRIT Grant
Congratulations to the Ariizumi/Cruz lab for being awarded a research grant from CPRIT (Cancer Prevention Research Institute of Texas). The goal of their project, entitled “Targeting the DC-HIL Receptor for Anti-Cancer Immunotherapy,” is to create a antibody to block the molecule DC-HIL. This antibody, by blocking DC-HIL, can be used in advanced melanoma patients to inhibit melanoma growth and to increase the cancer-killing ability of these patients’ immune system.